Pawel Derlatka
Overview
Explore the profile of Pawel Derlatka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kacperczyk-Bartnik J, Derlatka P, Danska-Bidzinska A, Pospiech K, Bartnik P, Urban A, et al.
J Cancer Educ
. 2025 Jan;
PMID: 39806077
Advances in gynaecologic oncology research lead to continuous updates in clinical guidelines. However, undergraduate medical education often lacks in-depth coverage of recent developments, limiting students' preparedness for evidence-based management of...
2.
Jankowska-Lombarska M, Grabowska-Derlatka L, Kraj L, Derlatka P
Cancers (Basel)
. 2024 Nov;
16(22).
PMID: 39594694
Background: The aim of this study was to determine the differences in diffusion-weighted imaging (DWI) and dynamic contrast enhancement (DCE) parameters between patients with peritoneal high-grade serous ovarian cancer (HGSOC)...
3.
Halaburda-Rola M, Grabowska-Derlatka L, Kraj L, Stec R, Derlatka P
Cancers (Basel)
. 2024 Nov;
16(21).
PMID: 39518010
Analysis of selected MRI parameters in initial MRI for the characterization of ovarian masses enables differentiation between mucinous ovarian carcinoma and metastatic ovarian tumors. A prospective analysis of contrast-enhanced MRI...
4.
Mruzek H, Kacperczyk-Bartnik J, Danska-Bidzinska A, Ciebiera M, Grabowska-Derlatka L, Derlatka P
Medicina (Kaunas)
. 2024 Oct;
60(10).
PMID: 39459487
In this comprehensive review supported by clinical examples, the authors explore the topic of cervical cancer in pregnancy, with emphasis on potential pre-cancer progression, the possibility of coexisting preinvasive and...
5.
Serefko A, Wrobel J, Szopa A, Dobrowolski P, Kluz T, Wdowiak A, et al.
Neurourol Urodyn
. 2024 Oct;
44(1):229-244.
PMID: 39402852
Aim: In the present study, we wanted to check whether TCS OX2 29 (TCS), a potent selective antagonist of OX2 receptors, would have positive effects in an animal model of...
6.
Rudnicka E, Jaron A, Kruszewska J, Smolarczyk R, Jazdzewski K, Derlatka P, et al.
J Clin Med
. 2024 Feb;
13(3).
PMID: 38337479
A complete gonadal dysgenesis (CGD) with 46,XY karyotype is known as the Swyer syndrome and belongs to the group of 46,XY differences of sex development (DSD). The main problem in...
7.
Grabowska-Derlatka L, Derlatka P, Halaburda-Rola M
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900244
(1) Background. The purpose of this study is to evaluate the diagnostic accuracy of a quantitative analysis of diffusion-weighted imaging (DWI) and dynamic contrast enhanced (DCE) MRI of mucinous ovarian...
8.
Jankowska-Lombarska M, Grabowska-Derlatka L, Derlatka P
Curr Oncol
. 2023 Jan;
30(1):506-517.
PMID: 36661689
Background: The aim of this pilot study was to evaluate the value of imaging techniques, including computed tomography (CT) and magnetic resonance imaging (MRI), in the diagnosis of a tumor-bowel...
9.
Kunikowska J, Bizon M, Pelka K, Derlatka P, Olszewski M, Krolicki L
Clin Nucl Med
. 2022 Dec;
48(2):e60-e66.
PMID: 36512649
Purpose Of The Report: Ovarian cancer is usually diagnosed in an advanced stage of disease due to the absence of specific symptoms and a lack of sensitive diagnostic methods. Prostate-specific...
10.
Derlatka P, Grabowska-Derlatka L, Halaburda-Rola M, Szeszkowski W, Czajkowski K
Cancers (Basel)
. 2022 May;
14(10).
PMID: 35626067
Background. The aim of our study was to describe the selected parameters of diffusion-weighted imaging (DWI) and perfusion dynamic contrast enhancement (DCE) MRI in primary tumors in patients with serous...